Analyses of objective response rate, progression-free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective study.
Takeshi HatanakaSatoru KakizakiTamon NagashimaMasashi NamikawaHiroki TojimaYasushi ShimadaDaichi TakizawaAtsushi NaganumaHirotaka AraiKen SatoNorifumi HarimotoKen ShirabeToshio UraokaPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2019)
The Barcelona Clinic Liver Cancer intermediate stage was the predictive factor affecting the ORR and PFS, and ALBI grade was a good predictive factor affecting the incidence of fatigue and decreased appetite.